Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-26-046201

CEO CFO gave up 1,411,982 shares (to pay taxes)

  • CEO CFO acquired 3,227,384 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Finley John David CEO CFO 2026-10-06 Option exercise +3,227,384 3,356,672 D
Finley John David CEO CFO 2026-10-06 Shares withheld for taxes −1,411,982 $1.49 $2,103,853 1,944,690 D
Derivatives
Finley John David CEO CFO 2026-10-06 Option exercise · Restricted Stock Units −3,059,800 6,119,600 D
Finley John David CEO CFO 2026-10-06 Option exercise · Restricted Stock Units −167,584 1,508,249 D
Loading xslF345X06/ownership.xml…